OOIR: Observatory of International Research

Papers

(The H4-Index of Journal of Antimicrobial Chemotherapy is 34. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)

Article	Citations
Correction to: Simultaneous and divergent evolution of resistance to cephalosporin/β-lactamase inhibitor combinations and imipenem/relebactam following ceftazidime/avibactam treatment of MDR Pseudomon	184
Low rates of complications and β-lactam resistance in viridans group streptococci bloodstream infection among cancer patients receiving chemotherapy	125
Correlation between rrs gene mutations and amikacin resistance in Mycobacterium abscessus: implications for fitness cost and clinical prevalence	99
Indolocarbazoles as host-directed therapeutics against intracellular infections by methicillin-resistant Staphylococcus aureus	95
Antimony used as rescue therapy in a kidney transplant recipient unresponsive to liposomal amphotericin B for chronic visceral leishmaniasis	73
Correction to: Phenotypic and genotypic analysis of antimicrobial resistance in Nocardia species	67
β-Lactam concentrations monitored in the early phase of community-acquired sepsis in the intensive care unit	63
Despite increasing use of integrase inhibitors to treat HIV infection, resistance to this class remains stable	62
Liposomal amikacin and Mycobacterium abscessus: intimate interactions inside eukaryotic cells	59
Establishment of epidemiological cut-off values of etimicin: a new fourth-generation aminoglycoside, against Escherichia coli, Klebsiella pneumoniae, Proteus mirabilis, Pseudom	55
Microdialysis assessment of gentamicin for second-line antimicrobial prophylaxis in abdominal surgery	52
Model-based translation of results from in vitro to in vivo experiments for afabicin activity against Staphylococcus aureus	51
Population pharmacokinetics of flucloxacillin as intermittent bolus infusion in patients with Staphylococcus aureus bloodstream infection	50
Prosthetic joint infections: 6 weeks of oral antibiotics results in a low failure rate	49
Fatal invasive pulmonary and cerebral aspergillosis due to triazole-resistant Aspergillus fumigatus with multiple CYP51A mutations	49
Blood telomere length gain in people living with HIV switching to dolutegravir plus lamivudine versus continuing triple regimen: a longitudinal, prospective, matched, controlled study	45
Molecular mechanism of envZ regulating β-lactam antibiotic resistance and virulence in Escherichia coli	45
Distinct molecular epidemiology of resistances to extended-spectrum cephalosporins and carbapenems in Enterobacter hormaechei in cats and dogs versus horses in France	44
Short-cycle three-day-per-week efavirenz/emtricitabine/tenofovir disoproxil fumarate therapy: a seven-year extension study	44
Management and outcomes of Stenotrophomonas maltophilia recovered from deep-site clinical specimens: a bicentric retrospective cohort study	43
Biliary pharmacokinetic/pharmacodynamic analysis of continuous infusion ceftazidime–avibactam in a case series of orthotopic liver transplant recipients	43
Antimicrobial use for the treatment of bacterial sexually transmitted infections among doxycycline post-exposure prophylaxis (DoxyPEP) users in Milan, Italy—right-to-reply	43
Emergence of the mobile RND-type efflux pump gene cluster tmexCD1-toprJ1 in Klebsiella pneumoniae clinical isolates in Japan	42
Epidemiology and clinical relevance of persistent bacteraemia in patients with Gram-negative bloodstream infection: a retrospective cohort study	42
Risk factors for suboptimal target attainment of commonly used ß-lactam antibiotics in older adults: a prospective cohort study	42

Overcoming antimicrobial resistance in Helicobacter pylori: the roles of collateral sensitivity and biofilm dynamics	41
NDM-5-producing Klebsiella pneumoniae ST258 in a university hospital in Argentina	40
A strategic discovery roadmap towards high-quality leads and drug development candidates for kinetoplastid diseases. Part 3: from lead towards a drug development candidate	40
Multicentre investigation of Wickerhamomyces anomalus fungemia in India: emerging resistance and mechanistic insights	39
Genomic and transcriptomic variation in Bordetella spp. following induction of erythromycin resistance	38
Emergence of a novel tet (X5) variant in Klebsiella spp. isolated from retail meat in Hainan, China	37
Uropathogenic Escherichia coli population structure and antimicrobial susceptibility in Norfolk, UK	34
Harnessing metabolic dependence-driven antibiotic synergy to eradicate tolerant Pseudomonas aeruginosa	34
Genomic insights into the tmexCD-toprJ : plasmid-mediated evolution, dissemination and diversity in bacterial populations	34
Neonatal sepsis due to NDM-1 and VIM-2 co-producing Pseudomonas aeruginosa in Morocco	34
The impact of palliative care consultation on reducing antibiotic overuse in hospitalized patients with terminal cancer at the end of life: a propensity score-weighting study	34